Silver plan enrollees saddled with high out-of-pocket costs
Enrollees in silver plans through the exchanges could be paying more than twice as much on prescription drugs than they would under a typical employer plan, new research finds. The report — commissioned by the Pharmaceutical Research and Manufacturers of America and conducted by actuarial firm Milliman — found exchange participants are paying a “far … Read more
